FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC) Print this page Cambridge, Mass. – December 17, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) has announced that the U.S. Food and Drug Administration (FDA) has approved Motegrity™ (prucalopride), a once-daily, oral treatment option for adults with Chronic Idiopathic Constipation (CIC).1 Motegrity, a… Read More »
At a packed 1981 City Hall committee meeting over a decade-old gay- rights bill, a top officer with the NYPD’s largest union told the crowd he was not aware of any “homosexual police officers” in the department. A sergeant from the Manhattan South Task Force suddenly rose to the podium behind him and uttered words… Read More »
As people get older it is quite noticeable how their dreams of wealth and status are slowly moderated and how health becomes a focus. Health is something that young people tend to take for granted. Their bodies are strong, and they bounce back from almost anything. Wear and tear and the demands of everyday use… Read More »